The Advanced Research Projects Agency for Health (ARPA-H), established by the Biden administration in the current federal fiscal year (FY) 2023, made several announcements last week that intend to advance its mission of creating breakthrough health technologies. The announcements include funding opportunities through an Agency-wide Open Broad Agency Announcement, an idea competition called the ARPA-H Dash and details about its site selection strategy. The ARPA-H Dash is a competition to identify revolutionary evidence-based ideas to transform health. Nominations for the ARPA-Dash will be accepted through an online portal between March 29 and April 7.
ARPA-H’s mission also includes balancing long-term scientific challenges with short-term research goals. President Biden continues to reaffirm the administration’s commitment to ARPA-H, proposing an increase in his FY 2024 federal budget for the agency, a total funding level of $2.5 billion (a 66.7% or $1 billion increase over FY 2023). The American College of Radiology® (ACR®) Academic Radiology Committee is continuing to track and share new opportunities within ARPA-H.
For more information, contact Katie Grady, ACR Government Affairs Director.
Make America Healthy Again
President Trump released an Executive Order (EO) establishing the "Make America Healthy Again (MAHA) Commission,” Feb. 13 to be led by the new Department of Health and Human Services Secretary Robert F. Kennedy Jr.
Read moreScope of Practice Bills Introduced At State Legislative Level
The American College of Radiology® (ACR®) is tracking more than 58 scope of practice bills across 22 states with more expected to be considered.
Read moreACR Others Challenge MAC Position on Minimally Invasive Arthrodesis of the Sacroiliac Joint
The American College of Radiology® (ACR®) and other medical specialty societies that use or perform interventional pain and spine procedures told three of the seven Medicare Administrative Contractors (MACs) that implementation of a new policy as written could limit access to a safe, effective and durable treatment option, potentially exacerbating healthcare disparities among Medicare patients.
Read more